Rudy Li
Stock Analyst at Chardan Capital
(4.96)
# 18
Out of 5,090 analysts
30
Total ratings
80%
Success rate
83.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintains: Buy | $80 → $330 | $247.99 | +33.07% | 3 | Oct 17, 2025 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $55 | $45.01 | +22.20% | 4 | Oct 7, 2025 | |
| IMUX Immunic | Initiates: Buy | $3 | $0.66 | +351.40% | 1 | Sep 29, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $15 | $13.43 | +11.69% | 1 | Sep 29, 2025 | |
| RVPH Reviva Pharmaceuticals Holdings | Initiates: Buy | $2 | $0.62 | +224.62% | 1 | Sep 29, 2025 | |
| PRTA Prothena Corporation | Maintains: Buy | $18 | $11.07 | +62.60% | 7 | Aug 28, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $24 | $30.87 | -22.25% | 4 | Aug 13, 2025 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $30 | $29.91 | +0.30% | 3 | Aug 12, 2025 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $20 | $12.35 | +61.94% | 4 | Aug 1, 2025 | |
| DRUG Bright Minds Biosciences | Maintains: Buy | $80 | $80.50 | -0.62% | 2 | May 21, 2025 |
Praxis Precision Medicines
Oct 17, 2025
Maintains: Buy
Price Target: $80 → $330
Current: $247.99
Upside: +33.07%
Xenon Pharmaceuticals
Oct 7, 2025
Maintains: Buy
Price Target: $55
Current: $45.01
Upside: +22.20%
Immunic
Sep 29, 2025
Initiates: Buy
Price Target: $3
Current: $0.66
Upside: +351.40%
Alto Neuroscience
Sep 29, 2025
Initiates: Buy
Price Target: $15
Current: $13.43
Upside: +11.69%
Reviva Pharmaceuticals Holdings
Sep 29, 2025
Initiates: Buy
Price Target: $2
Current: $0.62
Upside: +224.62%
Prothena Corporation
Aug 28, 2025
Maintains: Buy
Price Target: $18
Current: $11.07
Upside: +62.60%
Stoke Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $24
Current: $30.87
Upside: -22.25%
Centessa Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $30
Current: $29.91
Upside: +0.30%
Mind Medicine (MindMed)
Aug 1, 2025
Maintains: Buy
Price Target: $20
Current: $12.35
Upside: +61.94%
Bright Minds Biosciences
May 21, 2025
Maintains: Buy
Price Target: $80
Current: $80.50
Upside: -0.62%